SGLT 2 transporter mRNA (left) and protein (middle) and glucose transport (α-methyl-d-glucopyranoside) (right) are increased in cultured renal proximal.

Slides:



Advertisements
Similar presentations
Dr Fatahiya Kashif The Cell. Dr Fatahiya Kashif The Cell.
Advertisements

Precocious “AGE’ing” in Diabetes Precocious “AGE’ing” Effect of Type 1 Diabetes Background T1DM increases formation of advanced glycation end products.
Part 1 of 4. Program Editors Ralph Anthony DeFronzo, MD Professor of Medicine and Chief of the Diabetes Division University of Texas Health Science Center.
Supplementary Figure S4
Facilitated Diffusion
Nat. Rev. Nephrol. doi: /nrneph
Volume 94, Issue 3, Pages (September 2018)
Epinephrine Evokes Renalase Secretion via a-Adrenoceptor/NF-κB Pathways in Renal Proximal Tubular Epithelial Cells Kidney Blood Press Res 2014;39:
SGLT2 Inhibitors and Their Clinical Impact:
Figure 4 Expression of coagulation protease receptors in renal cells
Figure 1 Role of the kidney in glucose homeostasis
Figure 4 Effect of dapagliflozin on HbA1c and body weight
Nat. Rev. Nephrol. doi: /nrneph
Glycemic Control, Mealtime Glucose Excursions, and Diabetic Complications in Type 2 Diabetes Mellitus  P.J. Palumbo, MD  Mayo Clinic Proceedings  Volume.
TGF-β1 induces ILK activity in renal tubular epithelial cells.
Glucose handling by the kidney
Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.
Tubular Transport: Core Curriculum 2010
Part 9.
Figure 2 Glucose handling by the kidney
Volume 86, Issue 4, Pages (October 2014)
Figure 2 Roles of mTOR complexes in the kidney
Insulin and glucagon secretion: nondiabetic and diabetic subjects.
Volume 63, Issue 6, Pages (June 2003)
Volume 69, Issue 12, Pages (June 2006)
INT-767 treatment prevents the increase in renal inflammation and oxidative stress in diabetic DBA/2J mice. INT-767 treatment prevents the increase in.
INT-767 treatment prevents the increase in renal HIF and Glut1 expression and ER stress in diabetic DBA/2J mice. INT-767 treatment prevents the increase.
Volume 26, Issue 1, Pages (July 2017)
INT-767 treatment prevents renal lipid accumulation in diabetic DBA/2J mice. INT-767 treatment prevents renal lipid accumulation in diabetic DBA/2J mice.
Volume 83, Issue 5, Pages (May 2013)
TGF-β isoforms in renal fibrogenesis
A New Drug Target for Type 2 Diabetes
Volume 93, Issue 1, (January 2018)
Volume 29, Issue 2, Pages e4 (February 2019)
Changes in mRNA levels do not correlate with changes in protein levels in upf1Δ and xrn1Δ cells. Changes in mRNA levels do not correlate with changes in.
Localization of putative cholesterol-binding motifs in the homology model of human glucose transporter 1 (GLUT1) protein. Localization of putative cholesterol-binding.
AJKD Atlas of Renal Pathology: Toxic Acute Tubular Injury
Volume 54, Issue 4, Pages (October 1998)
Nitric oxide in acute renal failure: NOS versus NOS
Overview of the actions of SGLT2, including the role of SGLT2 in glucose reabsorption in the proximal tubule (A) and sites of action at which SGLT2 inhibitors.
Electrophoretic mobility shift assays for NF-κB in BRP (A) and BREC (B). Electrophoretic mobility shift assays for NF-κB in BRP (A) and BREC (B). Confluent.
Effect of metformin on glycemic control, insulin secretion, and insulin sensitivity in T2D. Effect of metformin on glycemic control, insulin secretion,
A–L: Xenin-25 amplifies the effects of GIP on plasma insulin, C-peptide, and glucose levels and ISRs in humans with NGT and IGT but not T2DM. A–L: Xenin-25.
Correlation between muscle Hsp-72 mRNA expression and rates of glucose and lipid turnover, as determined in protocol 2 (n = 36). Correlation between muscle.
Involvement of IRS-1 in L-783,281–stimulated increases in [Ca2+]i and exocytosis. Involvement of IRS-1 in L-783,281–stimulated increases in [Ca2+]i and.
Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.
A and B: Glucose reabsorption via SGLT1 and SGLT2 in normal and diabetic kidney. A and B: Glucose reabsorption via SGLT1 and SGLT2 in normal and diabetic.
Glucose handling by the kidney
A: Insulin-stimulated total, oxidative, and nonoxidative glucose disposal in subjects with NGT (open bars), IFG (dotted bars), IGT (striped bar), IFG/IGT.
Insulin secretion/insulin resistance (disposition) index (ΔINS/ΔGLU ÷ IR) in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT),
DNA methylation level of the Gpam promoter and GPAT-mediated TG/DG synthesis in the adult primary hepatocytes overexpressing Dnmt3b. DNA methylation level.
Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.
A single dose of liraglutide (Lira) (7. 5 μg/kg or 0
The effect of sulfonylurea (glibenclamide = glyburide) and metformin therapy on the plasma HbA1c concentration in newly diagnosed T2DM subjects in UKPDS.
A-E: Bcl family gene regulation in human islets cultured in high versus normal glucose. A-E: Bcl family gene regulation in human islets cultured in high.
The figure shows the mean±SD of glucose and insulin for the 2-hour OGTTs and MTTs for the 12 HP diet subjects and the 12 HC diets subjects. The figure.
Glucose reabsorption in the kidney.
Involvement of PKCα in downregulation of GLP-1 receptor by high glucose in isolated rat islets. Involvement of PKCα in downregulation of GLP-1 receptor.
COX-2 deletion in macrophages led to increased renal macrophage infiltration in diabetic mice. COX-2 deletion in macrophages led to increased renal macrophage.
C/EBPα induces HSD1 expression and is a substrate of USP2–45.
Assay of ROS accumulation in cells exposed to high levels of glucose.
Effect of GSK-3 inhibitors on basal and insulin-stimulated glucose uptake in human muscle cells. Effect of GSK-3 inhibitors on basal and insulin-stimulated.
Nrf2 was activated by high glucose–induced ROS production in HRMCs
Cell Culture Engineering XI
Correlations between leptin DNA methylation and 2-h post-OGTT glucose levels, within the IGT group (A and B), leptin DNA methylation and mRNA levels (C.
SGLT-2 mediates glucose reabsorption in the kidney.
KPT-9274 shows specificity for attenuation of PAK4 targets preferentially in RCC cells. KPT-9274 shows specificity for attenuation of PAK4 targets preferentially.
The Expanding Role of SGLT Inhibitors Across the Diabetes Spectrum
GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A:
Insulin secretion (hyperglycemic clamp) (A), insulin sensitivity (hyperinsulinemic-euglycemic clamp) (B), and glucose disposition index (GDI) (C) in adolescents.
Presentation transcript:

SGLT 2 transporter mRNA (left) and protein (middle) and glucose transport (α-methyl-d-glucopyranoside) (right) are increased in cultured renal proximal tubular epithelial cells of individuals with type 2 diabetes (T2DM) versus nondiabetic subjects (CON) (232). SGLT 2 transporter mRNA (left) and protein (middle) and glucose transport (α-methyl-d-glucopyranoside) (right) are increased in cultured renal proximal tubular epithelial cells of individuals with type 2 diabetes (T2DM) versus nondiabetic subjects (CON) (232). Ralph A. DeFronzo Diabetes 2009;58:773-795 ©2009 by American Diabetes Association